Alnylam Pharmaceuticals
Balance Sheet
Last updated:
The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Alnylam Pharmaceuticals's balance sheet done over the years? Its assets were worth $3,829,880,000 last year, which is more than in the previous period. 106% of Alnylam Pharmaceuticals’s total assets is currently financed by debt. Its liabilities reached the amount of $4,050,524,000, which means an increase by 9% compared compared to last year.
Debt to Assets
| 2014 | 1079595000 | 95.33M | 8.83% |
|---|---|---|---|
| 2015 | 1386510000 | 121.79M | 8.78% |
| 2016 | 1262810000 | 342.58M | 27.13% |
| 2017 | 1994730000 | 228.29M | 11.45% |
| 2018 | 1574802000 | 272.83M | 17.33% |
| 2019 | 2395134000 | 956.44M | 39.93% |
| 2020 | 3407061000 | 2.39B | 70.17% |
| 2021 | 3643304000 | 3.05B | 83.86% |
| 2022 | 3546359000 | 3.70B | 104.46% |
| 2023 | 3829880000 | 4.05B | 105.76% |
0HD2.L Balance Sheet (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets: | ||||||||||
Cash and cash equivalents | 812.68M | 866.39M | 822.15M | 499.04M | 547.18M | 420.14M | 645.36M | 193.61M | 180.89M | 75.17M |
Short term investments | 1.62B | 1.32B | 1.61B | 1.37B | 988.98M | 664.00M | 1.04B | 433.18M | 899.63M | 621.51M |
Net receivables | 327.78M | 237.96M | 198.57M | 602.41M | 43.01M | 18.76M | 34.00M | 23.33M | 8.29M | 39.93M |
Inventory | 89.14M | 128.96M | 86.36M | 75.20M | 56.34M | 24.06M | 1 | 1 | 1 | 0 |
Other current assets | 126.38M | 132.91M | 85.9M | 60.30M | 80.33M | 73.71M | 40.12M | 21.74M | 16.55M | 9.73M |
Total current assets | 2.98B | 2.69B | 2.80B | 2.61B | 1.71B | 1.20B | 1.76B | 671.87M | 1.10B | 746.36M |
Non-current assets: | ||||||||||
Property, Plant and Equipment | 725.78M | 738.63M | 733.63M | 706.51M | 646.37M | 320.65M | 181.9M | 114.57M | 27.81M | 21.74M |
Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Long term investments | 51.58M | 51.55M | 40.89M | 40.72M | 17.27M | 0 | 45.41M | 324.79M | 251.83M | 279.82M |
Other non-current assets | 69.80M | 63.93M | 60.20M | 45.04M | 15.62M | -320.65M | 2.67M | -439.37M | 1.47M | 31.66M |
Total non-current assets | 847.18M | 854.11M | 834.72M | 792.28M | 679.27M | 320.65M | 229.99M | 439.37M | 281.12M | 333.22M |
Total assets | 3.82B | 3.54B | 3.64B | 3.40B | 2.39B | 1.57B | 1.99B | 1.26B | 1.38B | 1.07B |
Liabilities | ||||||||||
| Current liabilities: | ||||||||||
Accounts payable | ||||||||||
Deferred revenue | 102.75M | 42.10M | 149.48M | 127.20M | 77.82M | 0 | 41.70M | 0 | 16.51M | 0 |
Short term debt | 96.50M | 82.25M | 77.62M | 50.18M | 27.68M | 0 | 0 | 0 | 0 | 0 |
Total current liabilities | 967.78M | 767.91M | 695.71M | 585.27M | 352.59M | 179.49M | 144.25M | 131.69M | 62.09M | 95.33M |
| Non-current liabilities: | ||||||||||
Long term debt | 2.58B | 2.26B | 1.82B | 1.24B | 276.13M | 30M | 30M | 150M | 0 | 0 |
Deferred tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other non-current liabilities | 496.61M | 212.58M | 98.96M | 37.90M | 9.33M | -30M | 10.97M | -150M | 6.73M | 0 |
Total non-current liabilities | 3.08B | 2.93B | 2.35B | 1.80B | 603.84M | 30M | 84.04M | 150M | 59.69M | 0 |
Total liabilities | 4.05B | 3.70B | 3.05B | 2.39B | 956.44M | 272.83M | 228.29M | 342.58M | 121.79M | 95.33M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |